MarketInOut Stock Screener Log In | Sign Up
 

Sol-Gel Technologies Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Sol-Gel Technologies Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization227.71 mln
Float1.32 mln
Earnings Date11/05/2026

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.57
Highly reliable

1-Year Forecast

152.50
Transformational upside

Relative Strength

42 / 100
Slightly lagging

Debt / Equity

0.02
Debt-free

Pre-Tax Margin

-910%
Severely loss-making

Business Description

Founded in Israel in 1997, Sol-Gel Technologies develops prescription skin treatments for conditions such as acne, rosacea, and rare genetic skin disorders. The company already sells two approved creams ? Twyneo for acne and Epsolay for rosacea ? while advancing additional treatments through clinical trials. Sol-Gel works with partners including Padagis, Galderma, and Searchlight Pharma to bring its products to markets across North America, Europe, Asia, and beyond.

Key Fundamentals

EPS-5.61
ROE-45.32
RPS0.62
ROIC-203
ROA-37.80
EBITDA, mln-16.34
EV / EBITDA-11.98
EV / EBIT-11.98
Revenue, mln1.79
EV / Revenue109

Quote Details

Last 69.45
Change 2.06 (3.06%)
Open 67.37
Volume 57,767
Turnover 4,011,918
Average Volume 39,487

Financial Ratios

Pre-Tax Profit Margin-910
Leverage Ratio1.12
Current Ratio10.37
Price / Book5.06
Price / Tangible Book5.06
Price / Free Cash Flow750
Debt / Equity0.02
Price / Sales121

Financial Strength

Altman Z-Score18.77
Piotroski F-Score 6 / 9
Beneish M-Score-3.57
1-Year Target Price152.50
Short Ratio2.55
Short % of Float13.78

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.09% 93 / 100   
1 Month 14.34% 95 / 100   
2 Months -13.3% 28 / 100   
6 Months -7.19% 39 / 100   
1 Year 77.62% 96 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog